Review: non-steroidal anti-inflammatory drugs may
reduce schizophrenia symptom severity in the short term when added to antipsychotics
Not exact matches
She says a small, unpublished study done by her group has shown that brain training for people in the early stages of
schizophrenia reduced psychotic
symptoms.
Brandon Staglin, now more than 2 decades into life with
schizophrenia, suggests that
reducing that stigma may make the disease easier to combat, for example by helping affected teens speak up about their
symptoms.
Antipsychotics
reduce the reality - bending
symptoms of
schizophrenia.
So not only they experienced
reduced symptoms of
schizophrenia, but their overall health increased as well, compared to the control group who didn't experience any improvements at all.
Theanine has the ability to increase relaxation without sedation, and
reduce positive and psychopathology anxiety
symptoms of
schizophrenia with high doses [1].
In addition, glycine has been shown to help treat obsessive - compulsive disorder and
reduce the
symptoms of
schizophrenia.
Autism and
schizophrenia share certain
symptoms, such as a
reduced capacity for communication and social interaction, Young says.
Review: clozapine
reduces relapse and
symptoms compared with typical neuroleptic drugs in
schizophrenia
After nine months, family - managed patients had fewer exacerbations of
schizophrenia, lower ratings of schizophrenic psychopathology, fewer hospital admissions, and a trend toward lower deficit
symptoms and
reduced neuroleptic dosage.
Moreover, men with depressive
symptoms have
reduced parasympathetic activity compared with control subjects, whereas no differences between depressed women and controls have been reported.44) Because the demographic characteristics of patients with various psychiatric disorders (e.g.,
schizophrenia, bipolar disorder, PTSD, and MDD) differ, the recruitment of separate groups of healthy controls that are well matched to individuals with each psychiatric disorder is necessary to clarify the HRV data.
Reviews of cognitive behaviour therapy in
schizophrenia indicate that evaluations are mainly case studies or uncontrolled trials.3 — 5 Four controlled trials have suggested that cognitive behavioural interventions can result in a reduction of psychotic and associated
symptoms that are resistant to medication in chronic
schizophrenia, 6 — 9 and a single trial has shown reduction of
symptoms in acute
schizophrenia.10 Although these trials are small and all suffer methodological limitations, particularly a lack of blind assessment, they represent encouraging evidence that cognitive behavioural interventions can have considerable benefits in
reducing persistent hallucinations and delusions.
Refractory
schizophrenia: adding aripiprazole to clozapine
reduces negative but not overall
symptoms
Targeting cognitive behaviour therapy to people with
schizophrenia whose prodromal
symptoms increase, may
reduce relapse rates and hospital admission compared with usual care.
Bupropion
reduces nicotine dependence and increases smoking cessation compared with control in people with
schizophrenia, without affecting positive, negative or depressive
symptoms.
Only 2 studies reviewed reported evaluations of staff training programmes designed to
reduce staff high EE.53, 54 Finemma et al53 developed a programme to increase nurses» knowledge of the
symptoms of
schizophrenia and ways of coping with impairments.